Longevity Health Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XAGE research report →
About the company
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids.
- CEO
- Janakiram Ajjarapu
- IPO
- 2021
- Employees
- 15
- HQ
- Pittsburgh, PA, US
Price Chart
- Market Cap
- $371.70K
- P/E
- -0.09
- P/S
- 0.21
- P/B
- -0.07
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
- Gross Margin
- 57.11%
- Op Margin
- -397.16%
- Net Margin
- -380.73%
- ROE
- 133.44%
- ROIC
- 109.73%
- Revenue
- $1.91M · 3701.44%
- Net Income
- $-6,905,282 · 33.40%
- EPS
- $-4.01 · -702.00%
- Op Income
- $-7,107,573
- FCF YoY
- 23.82%
- 52W High
- $8.27
- 52W Low
- $0.23
- 50D MA
- $0.31
- 200D MA
- $0.41
- Beta
- 0.39
- Avg Volume
- 1.94K
Get TickerSpark's AI analysis on XAGE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 16, 26 | Ajjarapu J. Ram | buy | 689,656 |
| Mar 16, 26 | Ajjarapu J. Ram | other | 0 |
| Oct 11, 24 | Bracken-Ferguson Kendra | other | 378,705 |
| Oct 11, 24 | Cassaday Bryan J. | other | 120,000 |
| Oct 11, 24 | Spenlehauer Gilles | other | 76,878 |
| Oct 11, 24 | Sturgeon Patrick A | other | 76,878 |
| Oct 11, 24 | Upton Richard A | other | 76,878 |
| Oct 11, 24 | Gregory Kathryn | other | 76,878 |
| Oct 11, 24 | Shukla Rajiv | other | 876,878 |
| Oct 11, 24 | Frisch Scott M. | other | 76,878 |
Our XAGE coverage
Recent articles, reports, and earnings notes.
No research on XAGE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XAGE report →Similar companies
Peers in the same neighborhood.